S2k guideline basal cell carcinoma of the skin (update 2023)
Basal cell carcinoma is the most common malignant tumor in the fair-skinned population and its incidence continues to rise. An update of the S2k guideline with the participation of all specialist societies familiar with the clinical picture and previous literature research is of great importance for the quality of care for affected patients. In addition to epidemiology, diagnostics and histology are discussed. After risk stratification, therapy is divided into topical, systemic and radiation therapy. Surgical removal remains the treatment of first choice in most cases. The approval of anti-PD1 inhibitors for locally advanced and metastatic tumors has opened up a new option in second-line therapy (after hedgehog inhibitors).
Authors
- Berenice M. Lang (ORCID: https://orcid.org/0000-0002-4679-3777)
- Stephan Ihrler (ORCID: https://orcid.org/0000-0002-6183-0249)
- Ludwig M. Heindl (ORCID: https://orcid.org/0000-0002-4413-6132)
- Lutz Tischendorf
- Markus Meißner (ORCID: https://orcid.org/0000-0002-5630-587X)
- Michael Weichenthal (ORCID: https://orcid.org/0000-0002-9060-4961)
- Thomas Dirschka (ORCID: https://orcid.org/0000-0001-7804-5311)
- Andrea Bauer (ORCID: https://orcid.org/0000-0002-4411-3088)
- Vinodh Kakkassery (ORCID: https://orcid.org/0000-0001-6212-8964)
- Roland Kaufmann (ORCID: https://orcid.org/0000-0002-1614-694X)
- Albrecht Krause‐Bergmann
- Klaus Fritz (ORCID: https://orcid.org/0000-0001-6225-4653)
- Max Schlaak (ORCID: https://orcid.org/0000-0002-1663-8098)
- Axel Hauschild (ORCID: https://orcid.org/0000-0002-1212-9587)
- Stephan Grabbe (ORCID: https://orcid.org/0000-0002-6863-8719)
- Dirk Vordermark (ORCID: https://orcid.org/0000-0001-8816-0508)
- Julia Welzel (ORCID: https://orcid.org/0000-0002-6099-7418)
- Michael Tronnier
- Panagiotis Balermpas (ORCID: https://orcid.org/0000-0001-5261-6446)
- Markus Follmann
- Bernhard Frerich (ORCID: https://orcid.org/0000-0001-6707-2429)
- Jorge Frank (ORCID: https://orcid.org/0000-0003-1439-8577)
- Hans‐Peter Howaldt
- Bernhard Klumpp (ORCID: https://orcid.org/0000-0003-2708-4999)
- Christoph R. Löser (ORCID: https://orcid.org/0000-0001-7028-3446)
- Susanne Wiegand (ORCID: https://orcid.org/0000-0003-1183-9226)
- Michael P. Schön (ORCID: https://orcid.org/0000-0002-0698-4130)
- Andreas Blum (ORCID: https://orcid.org/0000-0003-4087-5015)
- Michael Sachse
Institutions
- Goethe University Frankfurt (DE)
- University of Hildesheim (DE)
- Witten/Herdecke University (DE)
- University of Wuppertal (DE)
- University of Augsburg (DE)
- Johannes Gutenberg University Mainz (DE)
- Humboldt-Universität zu Berlin (DE)
- Rems-Murr-Klinikum (DE)
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- University Hospital of Zurich (CH)
- German Cancer Society (DE)
- University Hospital Schleswig-Holstein (DE)
- Universitätsmedizin Göttingen (DE)
- Klinikum Ludwigshafen (DE)
- University Hospital Frankfurt (DE)
- Klinikum Konstanz (DE)
- University Hospital Cologne (DE)
- University Hospital Carl Gustav Carus (DE)
- Klinikum Chemnitz (DE)
- University of Rostock (DE)
- Martin Luther University Halle-Wittenberg (DE)
- Freie Universität Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
- University of Tübingen (DE)
- Leipzig University (DE)
- University of Lübeck (DE)
Publication Details
- Journal
- JDDG Journal der Deutschen Dermatologischen Gesellschaft
- Published
- 2024-11-25
- DOI
- https://doi.org/10.1111/ddg.15566
- Citations
- 6
- Primary Topic
- Nonmelanoma Skin Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 2.32